Advertise on podcast: Thinking About Ob/Gyn

We talk with Dr. Jason Knight about what burnout really looks like in medicine and why a hard day is not the same thing as a broken relationship with the work. We push past buzzwords to name root causes, moral injury, and the practical steps clinicians and leaders can take to rebuild a sustainable healthcare workforce.  • distinguishing clinical exhaustion from burnout using emotional exhaustion, efficacy, and depersonalization  • why generic wellness programs fail when they are not matched to the real driver  • the limits of resilience and why burnout is a shared workplace problem  • the six-domain mismatch model: workload, control, reward, community, fairness, values  • how rural care, maternity deserts, and legal constraints amplify workload and control gaps  • moral injury in healthcare and how it differs from second victim syndrome  • building better measurement than once-a-year engagement surveys  • having productive leadership conversations by pairing data with real stories  • creating psychological safety for learners and addressing power dynamics  • returning to center through presence, journaling, and community  • using the Maslach Burnout Inventory to name what is mismatched  • normalizing “I need help” and reducing isolation as a risk factor  • Dr. Knight’s 78-Day Spiritual Reset and why reflection can support recovery  Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram  0:00 Welcome And Guest Setup 1:28 Wellness Without Root Cause 3:10 Burnout Versus Exhaustion Defined 6:56 Resilience And System Failures 12:34 Six Burnout Mismatch Domains 19:37 Moral Injury And Second Victim 27:13 Track Wellness Beyond Annual Surveys 29:21 How To Talk With Leadership 38:17 Returning To Center Through Presence 44:34 Practical Tools To Get Help 53:20 Reasons For Hope And Farewell Follow us on Instagram @thinkingaboutobgyn.

We dig into how good stories and elegant mechanisms can seduce clinicians into using fertility and surgical “add-ons” long before the evidence is ready. We also connect policy, access, and misinformation to a disturbing rise in ectopic pregnancy deaths, then end with what better studies should look like when patient safety is on the line.  • why low-dose naltrexone becomes a fertility add-on despite unclear mechanisms  • biologic plausibility versus proof, and why theory cannot replace trials  • what the available LDN data looks like, including weak endpoints and missing live birth outcomes  • practice inertia, file drawer bias, and when a therapy belongs in routine care  • ProPublica’s ectopic pregnancy mortality signal and how to interpret CDC WONDER data  • COVID-era care disruptions, hospital closures, and delayed early pregnancy evaluation  • Dobbs-era legal ambiguity, chilling effects, and implications for methotrexate timing  • a new Nature Medicine finding on ISM2 as an early biomarker for preeclampsia and fetal growth restriction  • V-NOTES versus vaginal hysterectomy trial design problems, including power, exclusions, and comparators  • conflicts of interest, blinding failures, and how low-quality studies pollute meta-analyses  Everybody remember to get your ABOG stuff done in the next month or so.  Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram.  0:34 Low-Dose Naltrexone For Fertility 8:38 Evidence Gaps And Practice Inertia 17:14 Ectopic Pregnancy Deaths Are Rising 22:00 Access Problems And Social Media Misinformation 24:15 Abortion Bans And Delayed Ectopic Care 29:32 ISM2 Biomarker For Preeclampsia Risk 32:31 V-Notes Versus Vaginal Hysterectomy Study 41:40 Power, Outcomes, And Unfair Comparisons 47:50 Conflict Of Interest And Broken Blinding 55:09 Where V-Notes Came From 1:01:31 Skills, Tradeoffs, And Final Reminders Follow us on Instagram @thinkingaboutobgyn.

Tara Chettiar joins as we talk through what the Lindsay Clancy case surfaces about postpartum mood disorders and why the public often misunderstands psychiatric illness when it gets filtered through legal arguments and internet certainty. We focus on practical clinical signals, especially sleep disruption, and what real safety planning and system reform should look like for postpartum families.  • why we avoid diagnosing a public case and instead look for system lessons  • how legal “insanity” clashes with the clinical spectrum of impairment  • why med lists get misread and what SSRI activation can signal  • baby blues versus postpartum depression and postpartum anxiety over time  • postpartum OCD intrusive thoughts versus psychosis and delusions  • sleep deprivation as the clearest danger sign and how it presents  • what families can do in an acute postpartum mental health crisis  • first line outpatient medication basics for OB GYN care  • why postpartum psychosis needs emergency level triage  • mother baby units and why the US has so few  • what a postpartum mental health safety plan includes, including guns and pills  • better screening in pregnancy, EPDS versus PHQ-9, and why anxiety matters  • workforce gaps and why OBs, family medicine, pediatrics, and ER teams need training  • Resources: Postpartum Support International at 1-800-944-4773 and text help, the National Maternal Mental Health Hotline at 833-TLC-Mama (852-6262), and 988  Be sure to check out thinking about obgyn.com for more information. And be sure to follow us on Instagram. 0:00 Welcome And Trigger Warning 1:30 Meet Tara And Her Work 7:10 Why The Clancy Case Matters 11:55 Legal Binary Versus Clinical Reality 12:50 Med Lists And Public Misreads 14:50 SSRI Insomnia And Bipolar Red Flags 18:15 Baby Blues Through Psychosis Spectrum 24:00 Intrusive Thoughts Versus Psychosis 28:13 Sleep Loss And Family Warning Signs 30:45 First Line Meds And Titration 34:55 ER Triage And Postpartum Advocacy 39:05 Mother Baby Units And Step Down Care 42:30 Safety Plans Means And Support 45:35 Screening Tools EPDS Over PHQ9 48:05 Workforce Gaps And Training Fixes 49:55 Policy Social Support And Paid Leave 52:40 Hotlines Resources And Closing Thoughts Follow us on Instagram @thinkingaboutobgyn.

We move from a Dolly Parton story to the very real ways policy, training, and clinical guidance shape what patients can access and what clinicians can safely provide. We break down the end of global OB billing, the risks of vaccine schedule “tweaks,” and why surgical convenience can quietly drive worse care.  • rural maternity deserts and why reimbursement must cover facility costs  • content warnings and protecting our own mental health while learning from high-profile perinatal cases  • the shift from global maternity fees to E/M problem-based prenatal visits  • work RVUs, delivery billing and why correct coding matters  • measles deaths, herd immunity and why splitting MMR increases missed protection  • robotic surgery dominance, laparoscopic deskilling and training priorities  • ACOG opportunistic salpingectomy guidance for ovarian cancer prevention  • practical techniques to complete salpingectomy during vaginal hysterectomy  • listener question on urinary retention and pudendal nerve injury myths  0:00 Welcome And A Dolly Parton Story 6:07 Perinatal Mental Health And Content Warnings 8:20 OB Billing Shifts From Global To E/M 15:17 Measles Deaths And The MMR Split 20:05 Robotic Dominance And Laparoscopy Deskilling 31:41 ACOG Salpingectomy Guidance And Ovarian Cancer 40:53 Vaginal Hysterectomy Tube Removal Techniques 53:10 Urinary Retention And Pudendal Nerve Myths 1:06:22 Final Takeaways And Where To Follow Thanks for listening be sure to check out thinkingaboutobyn.com for more information and be sure to follow us on Instagram  Follow us on Instagram @thinkingaboutobgyn.

JJ Cox joins us as we talk through what actually changes when we perform cesarean delivery in patients with morbid obesity, from incision planning to anesthesia risk to the wound that has to heal at home. We share practical tips, review key trials on negative pressure dressings and antibiotics, and focus on decisions that protect both safe delivery and lower wound complications.  • panniculus anatomy driving incision choice more than BMI  • using ultrasound to find the uterus when landmarks mislead  • paniculus retraction treated as an anesthesia maneuver  • distance and geometry limiting exposure and delivery technique  • planning the wound’s postoperative “home” before making the cut  • negative pressure wound therapy evidence including the 2020 JAMA trial and skin blistering risk  • skin glue vs standard dressings as competing narratives with limited data  • closing deep subcutaneous space in layers to reduce dead space  • avoiding staples and favoring subcuticular suture based on available evidence  • antibiotic prophylaxis realities including azithromycin dose questions and shortage workarounds  • extended postoperative antibiotics data shift when azithromycin is already used  • OR contamination habits including Yankauer discipline and glove-changing debate  • calling for help early and building a short pre-op plan to prevent downstream problems  Be sure to check out thinking about obgyn.com for more information. And be sure to follow us on Instagram.  0:00 Welcome And Guest Introduction 2:55 Why These C-Sections Are Higher Risk 7:00 Picking The Incision With Ultrasound 14:25 Panniculus Retraction Is Anesthesia Critical 17:35 Delivery Tips When Distance Is The Enemy 19:55 Think About The Wound Before Cutting 24:20 Negative Pressure Dressings What Trials Show 34:45 Subcutaneous Closure Sutures Beat Shortcuts 38:55 Antibiotics Dosing Azithromycin Reality Check 45:55 Contamination Control Yankauer And Gloves 52:10 Assistance Planning And Hemorrhage Limits 55:30 Meta-Analysis Takeaways And Closing Follow us on Instagram @thinkingaboutobgyn.

We challenge a few stubborn pieces of OB-GYN “common sense” and ask what the data actually supports, from trying to conceive after miscarriage to how we start and adjust ovulation induction. Then we shift into practical laparoscopy tips for obese patients and end with a sober look at how evidence quality shapes care, from magnesium sulfate debates to the rise in pregnancy-associated overdose deaths.  • why waiting a full cycle after first-trimester miscarriage lacks evidence for better outcomes  • why routine progestin withdrawal bleeds before letrozole or clomiphene can be unnecessary and even harmful  • how stair-stepping ovulation induction dosing can shorten time to ovulation  • four operating room tips for minimally invasive surgery in morbid obesity, including port geometry and Trendelenburg dry runs  • what a recent D&E fetal demise paper suggests about DIC and hemorrhage risk beyond 28 days  • why retrospective birth registry studies can mislead when randomized trial data exist  • how Medicaid timing findings highlight confounding rather than causation  • a clever low-port approach to perforated IUD removal using a transabdominal hysteroscope  • why overdose deaths are rising faster in pregnant and postpartum people and what fentanyl changes  Be sure to check out thinking about obgyn.com for more information and be sure to follow us on Instagram. 0:00 Welcome And What We’re Reading 0:29 The Myth Of Waiting After Miscarriage 1:08 Skip The Provera Withdrawal Bleed 7:49 Data On Conceiving Sooner 13:52 Laparoscopy Setup For Obese Patients 25:07 D&E After Second Trimester Demise 28:39 Magnesium Sulfate And Study Quality 39:06 Medicaid Timing And Confounding 44:57 Single Port Perforated IUD Removal 49:33 Overdose As Leading Pregnancy Associated Death 57:57 Book Shout Out And Closing Follow us on Instagram @thinkingaboutobgyn.

Howard Herrell and Stuart Winkler question long-standing OB-GYN habits that feel “routine” but do not add value, then replace them with evidence and practical decision-making. We move from hysterectomy follow-up and cuff dehiscence management to the data behind cesarean sutures, endometrial cancer evaluation in postmenopausal bleeding, and the ongoing shift to HPV-based cervical cancer screening.  • why routine 6 to 8 week vaginal cuff exams after hysterectomy may not prevent or predict dehiscence  • how telehealth post-op care can improve access while keeping symptom-driven safety nets  • four tips for evaluating and managing vaginal cuff dehiscence, including when laparoscopy matters  • what Ethicon discontinuing chromic and plain gut could mean for cesarean technique choices  • how the CORONIS trial informs chromic vs Vicryl decisions and why transfusion risk is part of the conversation  • where the 4 mm endometrial stripe rule came from and why it can fail in real-world care  • why persistent postmenopausal bleeding still warrants endometrial biopsy despite reassuring ultrasound  • how race, tumor subtype, and fibroids affect endometrial cancer detection and counseling  • the arc from Pap smear cytology to HPV DNA testing, vaccines, and primary HPV screening  • why self-collected HPV testing may raise screening uptake for patients avoiding speculum exams  Be sure to check out thinking about obgyn.com for more information, and be sure to follow us on Instagram. 0:00 Welcome And Today’s Game Plan 0:35 Rethinking The Six-Week Pelvic Exam 13:25 Four Practical Tips For Cuff Dehiscence 24:42 Chromic Gut Is Disappearing 35:40 CORONIS Trial And Cesarean Sutures 42:22 Postmenopausal Bleeding And The 4 mm Rule 53:12 HPV Testing Takes Over Screening Follow us on Instagram @thinkingaboutobgyn.

We follow the footnotes on a common gyn rule, then use that same evidence-first lens to question popular fertility add-ons and persistent pregnancy myths. Along the way, we talk pretest probability, counseling tradeoffs, and why simple cutoffs often replace better clinical reasoning.  • tracing the “biopsy Bartholin cysts after 40” claim back to weak citations  • using pretest probability and exam features to decide on selective biopsy  • weighing hysteropexy versus hysterectomy for prolapse with long-term cancer risk in mind  • breaking down a Lancet review of IVF add-ons and what actually shows benefit  • spotting how marketing and online forums amplify unproven fertility interventions  • reviewing data on sedentary time in pregnancy and why activity restriction persists  • debunking “walking progresses labor” with randomized trial evidence  • clarifying early diabetes testing as screening for preexisting diabetes and when A1C makes more sense than early glucose tolerance tests  Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram. 0:00 Welcome And What’s Ahead 0:23 Bartholin Cyst Biopsy Age Rule 14:17 Prolapse Repair With Uterus Preservation 21:45 IVF Add-Ons And The Lancet Review 37:35 Pregnancy Activity Myths And New Data 50:53 Early Diabetes Testing And A1C Follow us on Instagram @thinkingaboutobgyn.

Howard and guest hose Sivani Aluru unpack why the new PMOS name matters, how PCOS got tied to “cysts,” and what the evidence actually says about diagnosis, metabolic risk, and treatment. We also challenge a few habits we have all inherited, from pre-op antibiotic dosing to the way we talk about hormones, weight, and fertility with patients.  • the evidence gap behind 2 g vs 3 g cefazolin in obese cesarean patients and how practice inertia forms  • why PMOS shifts attention toward insulin resistance, metabolic screening, and multidisciplinary care  • how NIH, Rotterdam, and androgen excess criteria shape who gets diagnosed and who gets missed  • SHBG and free testosterone as a practical way to explain symptoms when total testosterone looks normal  • why ovarian follicles are not the same as painful ovarian cysts and why ultrasound can mislead  • patient frustration with “just take birth control” and how we explain progesterone protection for the endometrium  • lean PMOS, weight-focused bias, and realistic conversations about lifestyle change, GLP-1s, and bariatric surgery  • fertility takeaways from PPCOS II, metformin limitations, and what lifestyle trials suggest preconception  Be sure to check out thinkingaboutobgyn.com for more information, and be sure to follow us on Instagram. 0:00 Welcome And Guest Introduction 2:01 The 3-Gram Ancef Habit 12:02 PCOS Becomes PMOS 12:55 How The Criteria Got Complicated 22:00 Insulin Resistance And Free Testosterone 30:40 Hormone Panels And TikTok Myths 32:30 Ovarian Follicles Are Not “Cysts” 36:03 Treating Symptoms Without Dismissing People 46:12 Fertility Trials And Lifestyle Results 57:27 ACOG At 75 And Why Join Follow us on Instagram @thinkingaboutobgyn.

We push back on the idea that obstetrics “deserves” a malpractice crisis and explain how bad incentives and junk science can turn normal evidence-based care into courtroom blame. We also break down a few widely shared clinical myths and new research so we can practice with clearer eyes and less narrative noise. • placental grading on ultrasound as low-value data with poor predictive power and high reader variability  • how malpractice commentary can seed plaintiff-friendly arguments against evidence-based off-label use  • why blaming misoprostol or “high-dose” oxytocin oversimplifies multifactorial outcomes  • quality improvement bundles as useful tools but weak proof without controls or causal clarity  • how massive verdicts and paid expert testimony can clash with modern science on cerebral palsy and HIE  • the FAA’s five hazardous attitudes and practical antidotes for high-stakes clinical work  • new data on LEEP versus cold knife cone for CIN, recurrence, HPV clearance, and access tradeoffs  • genetics and BMI as major drivers of gut microbiome patterns, not influencer narratives  • what a 1993 Doppler trial can and cannot prove, plus why replication changes conclusions  Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram. 0:00 Welcome And Season Update 1:15 Placental Grading Myth On Ultrasound 6:44 Calling Out A Malpractice Influencer 14:06 The 2011 Policy Bundle Examined 23:20 What Drives The OB Malpractice Crisis 30:00 How Mega Verdicts Get Made 36:59 Five Hazardous Attitudes From Aviation 44:31 LEEP Versus Cone For CIN 48:04 Genetics And The Gut Microbiome 52:17 Does Doppler Ultrasound Harm Babies? 1:00:37 Recommendations And Closing Follow us on Instagram @thinkingaboutobgyn.

We sit down with Joshua Oommen to get nerdy about clinical reasoning, FDA standards, and why “good evidence” is harder to define than most of us admit. We challenge the reflex to trust p-values and meta-analyses, then test our instincts against real OBGYN examples where the literature has whiplashed practice.  • why the podcast is called Thinking About OBGYN and how clinical reasoning shapes our work  • the NEJM proposal to make one pivotal trial the FDA default and what “confirmatory evidence” might mean  • medical reversal, surrogate endpoints, and how trust erodes when practice changes late  • why Bayesian thinking fits how clinicians interpret tests, trials, and prior beliefs  • how meta-analyses fail through small study effects, publication bias, p-hacking, and heterogeneity  • the amnioinfusion comeback as a case study in applicability and overconfident conclusions  Be sure to check out thinking about obgyn.com for more information and be sure to follow us on Instagram.  0:00 Welcome And Today’s Big Question 3:48 Why “Thinking About OBGYN” Exists 11:54 The NEJM Push For One Trial 16:38 Medical Reversal And Trust Problems 24:43 AI Proteins And CRISPR Pressure Tests 32:33 Bayes Thinking Beyond P Values 36:43 Why Meta-Analyses Often Mislead 41:08 Bias And Heterogeneity Red Flags 46:24 Amnioinfusion And A Meta-Analysis Comeback 1:02:29 Final Warnings And How To Learn Follow us on Instagram @thinkingaboutobgyn.

We bring back the biggest takeaways from the ACOG ACSM, then move fast through the newest guidance and the newest hype shaping real OBGYN care. We focus on what the evidence actually supports, where practice still lags behind, and how “labels” can quietly push patients toward harm. • conference highlights including rural OBGYN access and what gets attention on the exhibit floor  • vitamin K shot refusal trends and why late bleeding still matters weeks after birth  • 2026 ACOG cervical cancer screening changes with primary HPV testing preferred for ages 30 to 65  • self-collected HPV screening and the systems needed to keep follow-up safe  • why annual Pap testing and cytology-only strategies increase overdiagnosis and can miss HPV risk  • postmenopausal bleeding workup shifting toward ultrasound plus endometrial biopsy up front  • large baby induction data and why outcomes can worsen without neonatal benefit  • third-trimester ultrasound screening performance and the real-world labeling effect  • early proof-of-concept therapy for preeclampsia targeting sFlt1 removal to prolong pregnancy  • hysterectomy duration and route as drivers of venous thromboembolism risk  • laboring down claims from retrospective reports versus randomized trial findings  • debunking physiologic third stage claims and reaffirming active management to prevent hemorrhage  Be sure to check out thinkingaboutobgyn.com for more information, and be sure to follow us on Instagram. 0:00 ACOG Meeting Takeaways And Rural Access 3:58 Vitamin K Refusal And Newborn Bleeding 6:37 Cervical Screening Moves Toward HPV 14:48 Postmenopausal Bleeding Now Needs Biopsy 20:00 Tylenol Data And Macrosomia Induction 28:34 Ultrasound Labeling Effect And Liability Fears 37:29 Removing sFlt1 To Buy Time 40:14 Longer Hysterectomy Surgeries Raise VTE Risk 42:14 Laboring Down Claims Versus RCT Reality 49:59 Counseling Fatigue Without Ignoring Risk 54:21 Third Stage Myths And Hemorrhage Prevention 58:42 Evidence Literacy And Closing Notes Follow us on Instagram @thinkingaboutobgyn.

We answer vaccine questions head-on, using real numbers to separate online fear from how vaccines, immunity, and public health actually work. We break down why diseases feel “gone,” what the modern schedule really exposes babies to, and how to spot misleading claims around ingredients, autism, and VAERS. Featuring Kate Moloney and our vaccine-hesitant friend Anah.  • why vaccine success makes diseases look eradicated while risk returns when coverage drops  • Stanford modeling estimates for measles, diphtheria, polio, and rubella without vaccination  • meningococcal meningitis basics, who is most at risk, and why outcomes can be catastrophic  • why clean water and sanitation do not explain protection from droplet-spread viruses  • what antigens are and why antigen exposure is far lower than decades ago  • downsides of delaying vaccines including longer vulnerability and more office visits  • aluminum, formaldehyde, and mercury claims explained with real-world comparisons  • “natural immunity” tradeoffs including measles pneumonia, immune amnesia, and SSPE  • long flu and post-viral inflammatory syndromes as quality-of-life consequences  • how vaccine schedules change, why the autism claim is debunked, and what profit incentives really look like  • what VAERS can and cannot tell you, plus how bias and viral claims distort reports  • why newborn hepatitis B vaccination exists, screening gaps, and true serious side effects  • rubella history and why vaccination primarily protects fetuses  1:05 Do We Vaccinate Too Much 3:32 Modeling A World Without Vaccines 6:20 Meningitis And Fast Catastrophes 8:28 Clean Water Is Not A Vaccine 11:02 Antigens And The Modern Schedule 15:44 Why Spacing Shots Can Backfire 16:53 Aluminum Formaldehyde Mercury Facts 22:00 Natural Immunity And Measles Damage 26:16 Long Flu And Post Viral Illness 28:26 Profit Fears And Autism Claims 31:26 VAERS Limits And Bad Math 38:39 Why Newborns Get Hepatitis B 45:09 Real Side Effects And Detox Scams 48:37 Rubella And Protecting Fetuses 51:57 Final Takeaways And Next Steps Be sure to check out thinkingaoutobgyn.com for more information and be sure to follow us on Instagram.  Follow us on Instagram @thinkingaboutobgyn.

We take on four stubborn myths in modern obstetrics and follow the evidence instead of the vibes, from thrombophilia testing to bed rest to seizure prophylaxis. We also spotlight a patient-empowering insulin strategy that may improve gestational diabetes outcomes faster than usual care.  • distinguishing recurrent pregnancy loss evaluation from venous thromboembolism testing  • focusing thrombophilia workups on antiphospholipid antibody syndrome when criteria are met  • explaining why MTHFR variants and PAI-1 polymorphisms do not belong in routine panels  • unpacking how social media and narrative fallacies keep low-value tests alive  • reviewing the AWARE trial and why activity restriction lacks benefit and carries harms  • clarifying reasonable pregnancy activity modifications versus false labor prevention claims  • assessing late preterm antenatal corticosteroids for twins and the hypoglycemia signal  • discussing inertia of practice and why weak evidence becomes hard to undo  • breaking down patient-led insulin titration for gestational diabetes and why it may reduce macrosomia  • evaluating laboring down and long-term pelvic floor outcomes plus statistical pitfalls  • answering a listener question on Keppra alternatives to magnesium for preeclampsia seizures  Be sure to check out thinking about obgyn.com for more information, and be sure to follow us on Instagram. 0:00 Welcome And What We’re Reviewing 0:28 Thrombophilia Testing After Miscarriage 3:51 What Belongs In A VTE Panel 5:55 MTHFR And PAI1 Myth Busting 13:36 Activity Restriction And The AWARE Trial 23:27 Practical Counseling Without False Promises 27:08 Late Preterm Steroids For Twins 32:53 Patient-Led Insulin Titration In GDM 38:38 Laboring Down And Pelvic Floor Outcomes 47:51 Keppra Versus Magnesium For Preeclampsia 1:00:25 Wrap Up And Where To Follow Follow us on Instagram @thinkingaboutobgyn.

We talk with Dr. Emily Donelan about how conflicting labor management guidelines can derail communication between nurses and physicians and quietly raise patient safety risks. We map the biggest friction points and lay out practical ways to reconcile guidance locally while pushing for a unified national approach.  • defining “communication dystocia” and why guideline discrepancies create real bedside conflict  • how evidence gaps drive teams toward institutional culture and inertia in practice  • the ARRIVE trial as a case study in differing priorities and framing  • a detailed induction vignette showing where amniotomy, oxytocin titration and uterine activity definitions collide  • why the 20 mU/min oxytocin threshold persists and what newer data suggests  • tachysystole rules, Category II tracings and how prescriptive language shapes nursing behavior  • delayed pushing versus pushing at complete dilation and the moral distress it can create  • the need for standardized evidence grading and cleaner citations across organizations  • a national interprofessional reconciliation program and who must be at the table  • one actionable step for tomorrow: stay curious and surface the real reason behind the disagreement  Be sure to check out thinking about obgyn.com for more information and be sure to follow us on Instagram. 0:01 Why Guideline Conflicts Matter 3:52 The ARRIVE Trial Framing Problem 12:23 A Labor Case Where Rules Collide 24:08 Oxytocin Thresholds And Litigation Fear 33:26 Pushing Timing And Moral Distress 38:05 Who Should Write Unified Guidance 44:04 Evidence Grading And Bedside Decisions 52:05 Inertia In Practice And De-Implementation 1:00:14 Takeaways Plus A No-Evidence Pet Peeve Follow us on Instagram @thinkingaboutobgyn.